[
  {
    "ts": null,
    "headline": "Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System",
    "summary": "Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 price target following FDA approval to expand the use of its Farapulse system for treating persistent atrial fibrillation (AFib). Previously approved for paroxysmal […]",
    "url": "https://finnhub.io/api/news?id=35d62454648d591673268fa393a2af89bb9bc68f82b40735df809a6889f02aa3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752585034,
      "headline": "Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System",
      "id": 135959744,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 price target following FDA approval to expand the use of its Farapulse system for treating persistent atrial fibrillation (AFib). Previously approved for paroxysmal […]",
      "url": "https://finnhub.io/api/news?id=35d62454648d591673268fa393a2af89bb9bc68f82b40735df809a6889f02aa3"
    }
  },
  {
    "ts": null,
    "headline": "Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings?",
    "summary": "BSX eyes strong Q2 with MedSurg momentum, solid Cardiovascular growth and benefits from key tech acquisitions.",
    "url": "https://finnhub.io/api/news?id=606184a6dd2df52162878d9f83379e295e7686da3bd04a68ad633601a042bf90",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752584520,
      "headline": "Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings?",
      "id": 135959746,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BSX eyes strong Q2 with MedSurg momentum, solid Cardiovascular growth and benefits from key tech acquisitions.",
      "url": "https://finnhub.io/api/news?id=606184a6dd2df52162878d9f83379e295e7686da3bd04a68ad633601a042bf90"
    }
  }
]